Demographics (n = number of patients) |
|
Age, year, mean ± SD |
72.54±9.96 |
65–79 years, n (%) |
204(83.61%) |
≥80 years, n (%) |
40(16.39%) |
Female, n (%) |
143(58.61%) |
Number of medications taken, mean ± SD |
8.76±4.35 |
Active chronic conditions,n(%) |
|
Hypertension |
171(70.08%) |
Heart disease |
138(56.56%) |
Hyperlipidemia |
73(29.92%) |
Diabetes mellitus |
70(28.69%) |
Osteoporosis |
42(17.21%) |
Gout |
36(14.75%) |
Constipation |
20(8.20%) |
Chronic obstructive pulmonary disease |
18(7.38%) |
Gastric ulcer/gastritis |
14(5.74%) |
Gastroesophageal reflux disease |
12(4.92%) |
Insomnia |
10(4.10%) |
Kidney disease |
8(3.28%) |
Others |
33(13.52%) |
Anatomical therapeutic chemical classification,n(%) |
|
A: Alimentary tract and metabolism |
|
A02 Drugs for acid related disorders |
82 |
A06 Drugs for constipation |
69 |
A10 Drugs used in diabetes |
122 |
A11 Vitamins |
24 |
B: Blood and blood-forming organs |
|
B01 Anti-thrombotic agents |
266 |
C: Cardiovascular system |
|
C01 Cardiac therapy |
102 |
C02 Antihypertensives |
684 |
C03 Diuretics |
45 |
C04 Peripheral vasodilators |
52 |
C05 Vasoprotectives |
33 |
C07 Beta blocking agents |
207 |
C08 Calcium channel blockers |
143 |
C09 Agents acting on the renin-angiotensin system |
245 |
C10 Lipid modifying agents |
134 |
G: Genital urinary and sex hormones |
|
G04 Urologicals |
15 |
M: Musculoskeletal system |
36 |
N: Nervous system |
|
N05 Psycholeptics |
45 |
(Anxiolytics, hypnotics, anti-psychotics i.e. neuroleptics) |
|
N06 Antidepressants |
12 |
No ATC code |
32 |